Prostate Specific Antigen download epub
by Michael K. Brawer
Prostate Specific Antigen book.
Prostate Specific Antigen book. Details (if other): Cancel.
Supplemented with helpful drawings, photographs, and tables that reinforce and clarify essential issues! Considering PSA as a monitor for cancer, Prostate Specific Antigen explores PSA levels during radiation, chemotherapy, and hormone therapy treatments. Increased PSA levels in older men.
Prostate-specific antigen: current status. CA: a cancer journal for clinicians
Prostate-specific antigen: current status. CA: a cancer journal for clinicians. Prostate-specific antigen (PSA) is the most important of all tumor markers in that it has significant applications in all aspects of the management of men with prostatic disease. Certainly, the mos. More).
To get the free app, enter your mobile phone number.
Prostate-Specific Antigen diagnostic use Prostatic Neoplasms diagnosis.
by Michael K Brawer and Roger Kirby. by Michael K Brawer and Roger Kirby. Guest contributor: Claus G Roehrborn. So is it a Providentially Sent Assay or a.
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland. PSA is produced for the ejaculate, where it liquefies semen in the seminal coagulum and allows sperm to swim freely. It is also believed to be instrumental in dissolving cervical mucus, allowing the entry of sperm into the uterus.
Prostate-specific antigen (PSA) is the most important marker for the detection and management of prostate cancer. PSA-based screening has been responsible for a profound downward stage migration in newly diagnosed prostate cancer compared to those detected in the pre-PSA era (1). This has been the result of the increased lead time for prostate cancer diagnosis that has resulted in the identification of prostate cancer earlier in the natural history of the disease (2). In addition, we have. Carter HB, Pearson JD, Metter JE, (1992) Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease.